皮膚じんましん治療の世界市場

皮膚じんましん治療の世界市場は2030年までに44億米ドルに達する見込み

2024年に29億米ドルと推定される皮膚じんましん治療の世界市場は、2024～2030年の分析期間においてCAGR 7.4%で成長し、2030年には44億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである慢性じんましんは、CAGR 8.3％を記録し、分析期間終了時には33億米ドルに達すると予測されます。急性じんましん分野は、分析期間中のCAGR成長率が5.0％と推定されます。

米国市場は7億8,580万米ドルと推定、中国はCAGR 11.7％で成長すると予測

米国の皮膚じんましん治療市場は、2024年に7億8,580万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 11.7%で推移し、2030年には9億3,900万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6%と7.2%と予測されています。欧州では、ドイツがCAGR 4.9%で成長すると予測されています。

世界の皮膚じんましん治療市場- 主要動向と促進要因まとめ

皮膚じんましんの治療が対症療法から病因に特化したアプローチに進化しているのはなぜか？

皮膚じんましん（蕁麻疹）は、真皮でのヒスタミン放出に起因する、盛り上がったかゆみを伴う膨疹を特徴とする一過性の発疹です。歴史的に、じんましんは第一世代の抗ヒスタミン薬とステロイド外用薬で治療されてきたが、現在では、急性型（6週間未満）と慢性型（6週間以上）を区別し、エビデンスに基づいた標的を絞った治療法へとシフトしています。このシフトは、自己抗体、肥満細胞過敏症、感染症、アレルゲン、ストレスなどの外的誘因などの免疫学的機序に対する理解の深まりによって推進されています。慢性蕁麻疹が、特に都市部やストレスの多い集団で蔓延するにつれ、皮膚科医やアレルギー専門医は、新世代の治療薬を含む段階的な治療アルゴリズムを採用するようになってきています。

急性じんましんは通常、セチリジン、ロラタジン、フェキソフェナジンなどの非鎮静性H1-抗ヒスタミン薬で消失します。しかし、慢性自然じんま疹（CSU）や誘発性じんま疹では、より高用量の抗ヒスタミン薬、H2ブロッカー、ロイコトリエン拮抗薬（モンテルカスト）、またはオマリズマブ（抗IgEモノクローナル抗体）などの生物学的製剤へのエスカレーションが必要となります。このような精密管理への動きは、症状コントロールを改善し、再発を減少させています。さらに、自己血清皮膚試験（ASST）、パッチテスト、好塩基球活性化試験などの診断ツールの使用は、個別化治療を支援し、難治性または自己免疫性症例を同定しています。

生物学的製剤と標的療法はどのように治療の情勢を変えているのか？

生物学的製剤は、特に抗ヒスタミン薬に反応しない患者に対する慢性蕁麻疹治療に革命をもたらしています。オマリズマブはもともと喘息治療薬として開発されたが、蕁麻疹の再燃頻度を減少させ、QOLを改善させるなど、蕁麻疹に強い有効性を示しています。オマリズマブは遊離IgEと結合し、肥満細胞や好塩基球の活性化を抑制します。現在、EAACI/GA²LEN/WAOによる蕁麻疹治療ガイドラインのステップ3で使用が推奨されています。現在進行中の臨床試験では、デュピルマブ（IL-4受容体阻害薬）やリゲリズマブ（次世代抗IgE抗体）など、下流の炎症経路をより正確に標的とする生物学的製剤が研究されています。

生物学的製剤の魅力は、良好な副作用プロファイル、長い投与間隔、迅速な作用にあります。しかし、多くの中低所得国では、高いコストと限られたアクセスが障壁となっています。この問題に対処するため、より手頃な価格で投与の利便性が高いバイオシミラーや皮下製剤の開発が進められています。シクロスポリンAのような免疫調節剤を重症CSUに再利用する取り組みも並行して行われており、特に生物学的製剤へのアクセスが限られている環境では、治療の選択肢が広がっています。

市販薬の分野では、抗ヒスタミン剤、カラミン、アロエベラ、メントールなどを配合した製剤が、より早く効果が現れ、長く効果が持続するように最適化されています。経皮吸収パッチや脂質ベースのクリームなどの局所デリバリーシステムは、全身吸収を最小限に抑えながら皮膚への浸透を高めるよう設計されています。このような技術革新により、全身的な薬物療法を行わずに即時的な症状コントロールを求める軽度または一過性のじんましん患者に対する治療手段が拡大しつつあります。

どのような患者層や環境要因が治療需要に影響を与えているか？

蕁麻疹はあらゆる年齢層で発症するが、慢性型は20～50歳の成人に多く、特に女性に多いです。ホルモンの変化、自己免疫素因、ストレス関連の誘因が性別や年齢に関連した疾患パターンに寄与しています。小児の蕁麻疹は多くの場合急性で、ウイルス感染、食物アレルギー、ワクチンに関連しており、一般的には体重調整抗ヒスタミン薬と回避戦略で管理されます。小児にやさしい液体製剤や眠くならない選択肢の必要性が、小児じんましん治療薬の技術革新を促しています。

都市化、公害、気候変動もじんましん発生の一因となっています。空気中アレルゲン、食品添加物、紫外線曝露、温度変化は、特に慢性誘発性じんま疹の誘因として認識されつつあります。先進工業国では、認知度の向上と早期診断により、第一選択薬と先進治療薬の処方量が増加しています。逆に新興国においては、過小診断、保険適用不足、伝統的な治療法への嗜好が、治療を求める行動に影響を及ぼし、最新の治療法へのアクセスを制限しています。

慢性蕁麻疹症例では、不安、睡眠障害、うつ病などの精神皮膚科学的相関が認識されつつあります。その結果、皮膚科と行動医学を組み合わせた統合的ケアモデルが、特に3次医療機関で試験的に導入されつつあります。ストレス軽減、除去食、アレルゲン回避などのライフスタイル管理戦略は、根本原因に対処し再燃頻度を減らすために、薬物療法と並んで推奨されるようになってきています。

皮膚じんましん治療市場の世界的成長を促進する要因とは？

皮膚じんましん治療の世界市場の成長は、慢性蕁麻疹の発生率の上昇、生物学的製剤の承認拡大、アレルギー関連皮膚疾患に対する意識の高まりなど、いくつかの要因によって牽引されています。世界のライフスタイルの変化、公害の増加、食事添加物などが、特に都市部における疾患有病率の上昇に寄与しています。同時に、患者教育や皮膚科医へのアウトリーチキャンペーンの改善により、より早期の診断と介入が可能となっています。

また、皮膚科に特化した遠隔医療、抗ヒスタミン薬への電子薬局でのアクセス、デジタルヘルスアプリケーションにじんましん治療が含まれるようになったことも、市場拡大に拍車をかけています。これらのプラットフォームは、処方更新、フレア追跡、症状日記を可能にし、長期的な疾患モニタリングと治療コンプライアンスを向上させています。高所得地域における生物製剤の保険適用と規制当局の承認パイプラインの拡大により、より多くの患者が先進的治療にアクセスできるようになっています。

また、次世代モノクローナル抗体、局所デリバリー・プラットフォーム、デュアルアクション抗ヒスタミン薬などを開発する製薬メーカーの動きも活発です。消費者ブランドは、軽度のじんましん緩和をターゲットとしたクリーンラベルのOTC製品で、植物性成分、コロイド状オートミール、ハーブ系抗ヒスタミン剤を活用しています。皮膚科学的認識、生物学的革新、個別化された治療プロトコルが進化を続けていることから、皮膚じんましん治療市場は堅調かつ持続的な世界的拡大が期待できます。

セグメント

タイプ（慢性じんましん、急性じんましん）、治療（抗炎症薬治療、かゆみ止め治療、抗ヒスタミン薬治療、その他の治療）、投与経路（経口投与、局所投与、非経口投与）、流通チャネル（病院薬局、オンライン流通チャネル、小売薬局）

調査対象企業の例

• AstraZeneca
• Allakos Inc.
• Amgen Inc.
• Celldex Therapeutics
• Escient Pharmaceuticals
• Eli Lilly and Company
• Genentech（Roche）
• Glenmark Pharmaceuticals
• GlaxoSmithKline plc
• Johnson & Johnson
• Kiniksa Pharmaceuticals
• Novartis AG
• Otsuka Holdings
• Pfizer Inc.
• Regeneron Pharmaceuticals
• Sanofi
• Takeda Pharmaceutical
• Teva Pharmaceutical Industries
• UCB Pharma
• Wockhardt Ltd.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Skin Hives Treatment Market to Reach US$4.4 Billion by 2030

The global market for Skin Hives Treatment estimated at US$2.9 Billion in the year 2024, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Chronic Hives, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Acute Hives segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$785.8 Million While China is Forecast to Grow at 11.7% CAGR

The Skin Hives Treatment market in the U.S. is estimated at US$785.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$939.0 Million by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Skin Hives Treatment Market - Key Trends & Drivers Summarized

Why Is the Management of Skin Hives Evolving From Symptom Control to Etiology-Specific Approaches?

Skin hives, or urticaria, are transient eruptions characterized by raised, itchy welts resulting from histamine release in the dermis. Historically managed with first-generation antihistamines and topical steroids, treatment paradigms for hives have shifted toward targeted, evidence-based protocols that distinguish between acute (lasting less than six weeks) and chronic (lasting six weeks or more) forms. This shift is being driven by a growing understanding of immunological mechanisms, such as autoantibodies, mast cell hypersensitivity, and external triggers like infections, allergens, or stress. As chronic urticaria becomes more prevalent, particularly in urban, high-stress populations, dermatologists and allergists are increasingly adopting stepwise treatment algorithms involving newer-generation therapies.

Acute hives typically resolve with non-sedating H1-antihistamines like cetirizine, loratadine, or fexofenadine. However, chronic spontaneous urticaria (CSU) and inducible urticaria require escalation to higher antihistamine doses, H2 blockers, leukotriene antagonists (montelukast), or biologics such as omalizumab (anti-IgE monoclonal antibody). This movement toward precision management is improving symptom control and reducing recurrence. Additionally, the use of diagnostic tools such as autologous serum skin tests (ASST), patch testing, and basophil activation tests is supporting individualized treatment and identifying refractory or autoimmune-driven cases.

How Are Biologics and Targeted Therapies Reshaping the Treatment Landscape?

Biologics are revolutionizing chronic urticaria treatment, particularly for patients unresponsive to antihistamines. Omalizumab, originally developed for asthma, has shown strong efficacy in CSU, reducing flare frequency and improving quality of life. It works by binding to free IgE, thereby preventing activation of mast cells and basophils. Its use is now recommended in step 3 of urticaria treatment guidelines by EAACI/GA²LEN/WAO. Ongoing clinical trials are investigating other biologics-such as dupilumab (IL-4 receptor inhibitor) and ligelizumab (a next-gen anti-IgE antibody)-to target downstream inflammatory pathways more precisely.

The appeal of biologics lies in their favorable side effect profiles, long dosing intervals, and rapid action. However, high costs and limited access remain barriers in many low- and middle-income countries. To address this, biosimilars and subcutaneous formulations with better affordability and administration convenience are being developed. Parallel efforts in repurposing immunomodulators like cyclosporine A for severe CSU are extending treatment options, especially in settings with limited biologics access.

In the over-the-counter segment, formulations containing antihistamines, calamine, aloe vera, and menthol are being optimized for faster onset and longer-lasting relief. Topical delivery systems-such as transdermal patches and lipid-based creams-are being engineered to enhance skin penetration while minimizing systemic absorption. These innovations are expanding the therapeutic arsenal for patients with mild or transient hives seeking immediate symptom control without systemic medication.

Which Patient Demographics and Environmental Factors Are Influencing Treatment Demand?

Urticaria affects individuals of all ages, but chronic forms are more commonly reported among adults aged 20-50, with a notable prevalence among women. Hormonal changes, autoimmune predispositions, and stress-related triggers contribute to gender and age-related disease patterns. Pediatric urticaria is often acute, related to viral infections, food allergies, or vaccines, and is typically managed with weight-adjusted antihistamines and avoidance strategies. The need for child-friendly liquid formulations and non-drowsy options is driving innovation in pediatric hives treatment products.

Urbanization, pollution, and climate variability are also contributing to hives outbreaks. Airborne allergens, food additives, UV exposure, and thermal changes are increasingly recognized as triggers, especially for chronic inducible urticaria. In industrialized nations, rising awareness and early diagnosis are translating into higher prescription volumes for both first-line and advanced therapies. Conversely, in emerging markets, underdiagnosis, lack of insurance coverage, and preference for traditional remedies are influencing care-seeking behavior and limiting access to modern treatments.

Psychodermatological correlations-such as anxiety, sleep disruption, and depression-are gaining recognition in chronic urticaria cases. As a result, integrative care models combining dermatology with behavioral health are being piloted, especially in tertiary centers. Lifestyle management strategies, including stress reduction, elimination diets, and allergen avoidance, are increasingly recommended alongside pharmacotherapy to address root causes and reduce flare frequency.

What Forces Are Driving Global Growth in the Skin Hives Treatment Market?

The growth in the global skin hives treatment market is driven by several factors including the rising incidence of chronic urticaria, expanded biologic approvals, and growing awareness of allergy-related skin disorders. Global lifestyle changes, increasing pollution, and dietary additives are contributing to higher disease prevalence, particularly in urban environments. Concurrently, improved patient education and dermatologist outreach campaigns are enabling earlier diagnosis and intervention.

Market expansion is also being fueled by advancements in dermatology-focused telehealth, e-pharmacy access to antihistamines, and the inclusion of hives treatment in digital health applications. These platforms are enabling prescription renewals, flare tracking, and symptom diaries-improving long-term disease monitoring and treatment compliance. Insurance coverage of biologics in high-income regions and expanded regulatory approval pipelines are making advanced therapies accessible to more patients.

The market is also witnessing significant activity from pharmaceutical manufacturers developing next-generation monoclonal antibodies, topical delivery platforms, and dual-action antihistamines. Consumer brands are leveraging botanicals, colloidal oatmeal, and herbal antihistamines in clean-label OTC products targeting mild hives relief. With dermatological awareness, biological innovation, and personalized treatment protocols continuing to evolve, the skin hives treatment market is positioned for robust and sustained global expansion.

SCOPE OF STUDY:

The report analyzes the Skin Hives Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Chronic Hives, Acute Hives); Treatment (Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment, Other Treatments); Administration Route (Oral Administration, Topical Administration, Parenteral Administration); Distribution Channel (Hospital Pharmacies, Online Distribution Channel, Retail Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• AstraZeneca
• Allakos Inc.
• Amgen Inc.
• Celldex Therapeutics
• Escient Pharmaceuticals
• Eli Lilly and Company
• Genentech (Roche)
• Glenmark Pharmaceuticals
• GlaxoSmithKline plc
• Johnson & Johnson
• Kiniksa Pharmaceuticals
• Novartis AG
• Otsuka Holdings
• Pfizer Inc.
• Regeneron Pharmaceuticals
• Sanofi
• Takeda Pharmaceutical
• Teva Pharmaceutical Industries
• UCB Pharma
• Wockhardt Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Skin Hives Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic and Idiopathic Urticaria Spurs Demand for Targeted Therapies
  • Increased Availability of OTC Antihistamines and Topical Agents Expands Consumer Access
  • OEM Development of Biologics and Monoclonal Antibodies Enhances Treatment Precision
  • Growing Prevalence of Autoimmune and Allergic Conditions Drives Long-Term Medication Use
  • Healthcare Campaigns and Allergy Awareness Weeks Elevate Public Engagement and Diagnosis
  • Surge in Digital Symptom Trackers Encourages Timely Treatment and Medication Adherence
  • Expanded Use of Combination Therapies Improves Patient Quality of Life Metrics
  • Demand for Fast-Acting and Non-Sedative Formulations Strengthens Retail Market Penetration
  • Pharmaceutical Advances in H1 and H2 Antihistamines Promote Customized Regimens
  • Growth of Home-Based Allergy Management Tools Drives Telemedicine Consultations
  • OEM Partnerships With Research Institutions Accelerate Biologic Pipeline for Severe Hives
  • Rise in Organic and Herbal Alternatives Broadens Portfolio of Natural Treatment Options
  • Direct-to-Consumer Campaigns by Dermatology Brands Increase Product Visibility
  • Regulatory Approval of Novel Immunomodulators Spurs Competitive Differentiation
  • Global Climate Change and Pollution Levels Influence Allergen Exposure and Triggers
  • Increased Use of Mobile Health Apps Enhances Patient Reporting and Physician Monitoring
  • Emphasis on Pediatric-Friendly Formulations Expands Adoption in Children
  • Focus on Preventive Skin Care Products Strengthens Adherence for Recurrent Cases
  • Improved Clinical Trials for Chronic Urticaria Drives Better Efficacy Metrics
  • Healthcare Provider Education Initiatives Improve Diagnosis Accuracy and Early Intervention
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Skin Hives Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Skin Hives Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Skin Hives Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Skin Hives Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Chronic Hives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Chronic Hives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Chronic Hives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Acute Hives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Acute Hives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Acute Hives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anti-Inflammatory Drugs Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Anti-Inflammatory Drugs Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Anti-Itch Drugs Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Anti-Itch Drugs Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Anti-Itch Drugs Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Antihistamines Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Antihistamines Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Antihistamines Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Topical Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Topical Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• JAPAN
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• CHINA
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: China 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: China 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: China 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• EUROPE
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Skin Hives Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Europe 16-Year Perspective for Skin Hives Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Europe 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• FRANCE
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: France 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: France 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: France 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• GERMANY
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Germany 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Germany 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Germany 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Italy 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Italy 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Italy 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 140: UK Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: UK 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: UK 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: UK 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Spain 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Spain 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Spain 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Russia 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Russia 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Russia 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Skin Hives Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Australia 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Australia 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Australia 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• INDIA
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 215: India Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: India 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: India 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: India 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: South Korea 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: South Korea 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: South Korea 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Skin Hives Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Latin America 16-Year Perspective for Skin Hives Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Latin America 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Latin America 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Argentina 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Argentina 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Argentina 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Brazil 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Brazil 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Brazil 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Mexico 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Mexico 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Mexico 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Skin Hives Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Middle East 16-Year Perspective for Skin Hives Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Middle East 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Middle East 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Iran 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Iran 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Iran 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Israel 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Israel 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Israel 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: UAE 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: UAE 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: UAE 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030
• AFRICA
  • Skin Hives Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Skin Hives Treatment by Type - Chronic Hives and Acute Hives - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Skin Hives Treatment by Type - Chronic Hives and Acute Hives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Africa 16-Year Perspective for Skin Hives Treatment by Type - Percentage Breakdown of Value Sales for Chronic Hives and Acute Hives for the Years 2014, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Skin Hives Treatment by Distribution Channel - Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Africa 16-Year Perspective for Skin Hives Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Online Distribution Channel and Retail Pharmacies for the Years 2014, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Skin Hives Treatment by Treatment - Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Africa 16-Year Perspective for Skin Hives Treatment by Treatment - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs Treatment, Anti-Itch Drugs Treatment, Antihistamines Treatment and Other Treatments for the Years 2014, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Skin Hives Treatment by Administration Route - Oral Administration, Topical Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Skin Hives Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Topical Administration and Parenteral Administration for the Years 2014, 2025 & 2030

IV. COMPETITION